Patients & ProvidersHow SelfWrap WorksCompanyNewsClinical Trial
Follow us for updates:LinkedIn
All News

VenoStent Awarded LaunchTN Funds

Nov 13, 2018

We are excited to (belatedly) announce that as of September 27, we have been awarded $112K in non-dilutive Grant Matching funds for our Phase I STTR project awarded by the National Science Foundation.

A mouthful, that may be, what it means in practice is that the state of Tennessee, due to our efforts to develop the Tennessee economy via our entrepreneurial endeavors, have awarded us money to assist in that goal.

This is huge for a company at our stage of development as it will provide critical funding towards our first large-animal (swine) preclinical trials. This will de-risk subsequent investments that we receive and help with our long term development plans.

We are extremely grateful to the state of Tennessee in their vote of confidence for us and we are especially grateful to the folks at LaunchTN!

SelfWrap is currently in the research and development phase and is not available for sale in any country. Investigational Device. Limited by Federal Law to Investigational Use.

COI Policy© 2024 VenoStent, Inc. All rights reserved.
Contact Usinfo@venostent.com
2450 Holcombe Blvd, Suite J Houston, TX 77021
Follow Us